Organization
Laekna Limited
6 clinical trials
Clinical trial
An Open Label Randomized Active Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients With Platinum-Resistant Ovarian CancerStatus: Active (not recruiting), Estimated PCD: 2023-07-31
Clinical trial
A Phase I/II Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate CancerStatus: , Estimated PCD: 2023-10-09
Clinical trial
A PhI Dose Escalation Study of LAE005+Afuresertib+Nab_Paclitaxel in Advanced Solid Tumors and PhII Study to Evaluate the Safety and Efficacy of LAE005+Afur+Nab_Paclitaxel or LAE005/Afur+Nab-Paclitaxel in Locally Advanced or mTNBCStatus: Completed, Estimated PCD: 2023-12-11
Clinical trial
A Phase I/II Dose-Escalation and Efficacy Study of LAE001/Prednisone Plus Afuresertib in Patients With Metastatic Castration-resistant Prostate Cancer Following Standard of Care TreatmentStatus: Active (not recruiting), Estimated PCD: 2023-12-27
Clinical trial
A Phase I/II Dose-Escalation and Efficacy/Safety Study of Afuresertib Plus Sintilimab Plus Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1 TreatmentStatus: Recruiting, Estimated PCD: 2024-08-31
Clinical trial
In Vivo Absorption, Metabolism, Excretion (AME) Clinical Study of [14C]Afuresertib in Healthy Chinese Male Adults - Human Mass Balance and Biotransformation Study of [14C]AfuresertibStatus: Completed, Estimated PCD: 2022-10-21